Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Transport Pharmaceuticals, Inc.

Transport Pharmaceuticals, Inc. is developing a proprietary iontophoretic drug delivery technology applicable to multiple dermatological diseases, with an initial focus on herpes labialis, or cold sores. The company's lead product enables the delivery of high doses of acyclovir, an approved cold sore treatment, directly to impacted skin areas, addressing a primary barrier to effective treatment of herpes labialis. The company operates under the management of neXus therapeutics, inc.NeXus is a biopharmaceutical management company that employs an "essential product development" paradigm to enhance the development process of early stage drugs and combination products. NeXus has an exclusive agreement with Transport to manage the company's business operations and product design and development.


Contact Details:
161 Worcester Road, Suite 402
Framingham
Massachusetts
01701
United States of America
Tel: 508-872-0433
Fax:508-872-0922
Email:jsantucci@transportpharma.com
WWW:

www.transportpharma.com/




Loading...

BioNews Results for Transport Pharmaceuticals, Inc.:

Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Th
Pharma Live:  Nov 21 2009 2:54AM Matching: transport pharmaceuticals inc
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome
SmartBrief:  Nov 20 2009 6:49AM Matching: transport pharmaceuticals inc
Paloma Pharmaceuticals, Inc. Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Can
BioSpace:  Nov 19 2009 7:17PM Matching: transport pharmaceuticals inc
Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Th
PharmiWeb:  Nov 19 2009 1:40AM Matching: transport pharmaceuticals inc
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP88
Pharmacy Choice:  Nov 19 2009 10:39PM Matching: transport pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Transport Pharmaceuticals, Inc. news.

Transport Pharmaceuticals, Inc. Patents:

US Patent No.Title
7127285 Systems and methods for electrokinetic delivery of a substance
7016724 Electrokinetic delivery system for self-administration of medicaments and methods therefor

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 414 times since April 2007, the link to the organisation's website has been followed 63 times

Recent Search Terms used to find this page: transport pharmaceuticals inc.2009 | transport pharmaceuticals 2009 | transport pharmaceuticals 2009 | transport pharmaceuticals inc news | transport pharmaceuticals home page | Transport Pharmaceuticals | transport pharma | transport pharma | transport pharma | transport pharmaceuticals | .

Search for more companies in Framingham

Search for more companies in Massachusetts



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Transport Pharmaceuticals, Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.